{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:39:26Z","timestamp":1794472766154,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.074","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:40:33Z","timestamp":1236246033000},"page":"2662-2668","source":"Crossref","is-referenced-by-count":29,"title":["In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB)"],"prefix":"10.1016","volume":"27","author":[{"given":"M. Kimberly","family":"Knowles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheona","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Nadin-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Wandeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.074_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","article-title":"Elimination of rabies from red foxes in Eastern Ontario","volume":"37","author":"MacInnes","year":"2001","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7589\/0090-3558-44.1.71","article-title":"ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989\u20132004","volume":"44","author":"Fehlner-Gardiner","year":"2008","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.074_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7589\/0090-3558-26.1.99","article-title":"Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis)","volume":"26","author":"Rupprecht","year":"1990","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1073\/pnas.83.20.7947","article-title":"Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine","volume":"83","author":"Rupprecht","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.02.074_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.02.074_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/354520a0","article-title":"Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine","volume":"354","author":"Brochier","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.02.074_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7589\/0090-3558-34.2.228","article-title":"First North American field release of a vaccinia-rabies glycoprotein recombinant virus","volume":"34","author":"Hanlon","year":"1998","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7589\/0090-3558-37.2.265","article-title":"Emergency response to raccoon rabies introduction into Ontario","volume":"37","author":"Rosatte","year":"2001","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib10","first-page":"363","article-title":"Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein","volume":"51","author":"Tolson","year":"1987","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2009.02.074_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7589\/0090-3558-43.1.124","article-title":"Rabies challenge of captive striped skunks (Mephitis mephitis) following oral administration of a live vaccinia-vectored rabies vaccine","volume":"43","author":"Grosenbaugh","year":"2007","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib12","series-title":"Fields virology","first-page":"2265","article-title":"Adenoviridae: the viruses and their replication","author":"Shenk","year":"1996"},{"key":"10.1016\/j.vaccine.2009.02.074_bib13","series-title":"Vaccines: new approaches to immunological problems","first-page":"363","article-title":"Adenovirus-based expression vectors and recombinant vaccines","author":"Graham","year":"1992"},{"key":"10.1016\/j.vaccine.2009.02.074_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/161.1.27","article-title":"A recombinant human adenovirus vaccine against rabies","volume":"161","author":"Prevec","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(96)00012-6","article-title":"Human adenovirus type 5 vectors expressing rabies glycoprotein","volume":"14","author":"Yarosh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.074_bib16","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.211423298","article-title":"Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"98","author":"Amexis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.02.074_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2004.06.032","article-title":"Recombinant viruses obtained from co-infection in vitro with a live vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus display different plaque phenotypes and loss of the transgene","volume":"23","author":"Hansen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.074_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.20889","article-title":"Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene","volume":"79","author":"Laassri","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2009.02.074_bib19","first-page":"157","article-title":"In vitro assessments of the genetic stability of a live recombinant human adenovirus vaccine against rabies","volume":"59","author":"Lutze-Wallace","year":"1995","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2009.02.074_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/biol.1995.0045","article-title":"Characterization of a Human Adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated Skunks","volume":"23","author":"Lutze-Wallace","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.02.074_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/150.1.92","article-title":"A new animal model for human and respiratory tract disease due to adenovirus","volume":"150","author":"Pacini","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.074_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.02.074_bib23","unstructured":"Elmgren, L.D., 1999. Epitope mapping of lyssavirus structural proteins. Ph.D. Thesis. University of Ottawa, Ottawa, Ontario, Canada."},{"key":"10.1016\/j.vaccine.2009.02.074_bib24","series-title":"Laboratory techniques in rabies","first-page":"321","article-title":"Methods of calculation","author":"Lorenz","year":"1973"},{"key":"10.1016\/j.vaccine.2009.02.074_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0042-6822(92)90082-Z","article-title":"The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2","volume":"186","author":"Chroboczek","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.02.074_bib26","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","article-title":"The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools","volume":"25","author":"Thompson","year":"1997","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2009.02.074_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/JVI.67.1.101-111.1993","article-title":"Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)","volume":"67","author":"Prince","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.074_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.vaccine.2004.06.031","article-title":"In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife","volume":"23","author":"Dietzschold","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.074_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/294275a0","article-title":"Structure of the glycoprotein gene in rabies virus","volume":"294","author":"Anilionis","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.02.074_bib30","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia recombinant containing the rabies virus glycoprotein gene","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.02.074_bib31","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1128\/JVI.67.10.5911-5921.1993","article-title":"Packaging capacity and stability of human adenovirus type 5 vectors","volume":"67","author":"Bett","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.074_bib32","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/104303403766682278","article-title":"Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region of growth properties of first-generation adenoviruses","volume":"14","author":"Youil","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2009.02.074_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008135928310","article-title":"Immunomodulatory functions encoded by the E3 transcription unit of Adenoviruses","volume":"21","author":"Burgert","year":"2000","journal-title":"Virus Genes"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:00:09Z","timestamp":1589623209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003314"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}